| A Systemic Screening for TB Disease in High-risk Groups in Barcelona (NCT06706596) | Fundació Institut Germans Trias i Pujol | 2022-07-22 |
| A Retrospective Cohort Study to Develop Markers for TB Severity and Treatment Progress (NCT05477966) | Jae-Joon Yim | 2022-07-18 |
| Effect of Integrating Traditional Tuberculosis Care With Modern Health Care on Case Detection (NCT05236452) | Bahir Dar University | 2022-07-01 |
| A Phase 1, Drug-Drug Interaction Study of TBAJ-876 in Healthy Adults (NCT05526911) | Global Alliance for TB Drug Development | 2022-06-30 |
| Clinic-based Versus Hotspot-focused Active TB Case Finding (NCT05285202) | Johns Hopkins University | 2022-06-01 |
| EBA, Safety and Tolerability of Sanfetrinem Cilexetil (NCT05388448) | TASK Applied Science | 2022-04-21 |
| Tuberculosis - Learning the Effect of Parasites and Reinforcing Diets (NCT05048485) | Boston Medical Center | 2022-04-09 |
| Childhood TB Sequel (NCT05325125) | London School of Hygiene and Tropical Medicine | 2022-03-29 |
| Four Months Moxifloxacin Containing Daily Regimen Study Among New Pulmonary Tuberculosis Patients (NCT05047055) | Tuberculosis Research Centre, India | 2022-03-15 |
| Human-centered Design and Communities of Practice to Improve Home-based Tuberculosis Contact Investigation in Uganda (NCT05640648) | Yale University | 2022-03-07 |
| INSTI's For The Management of HIV-associated TB (NCT04734652) | Centre for the AIDS Programme of Research in South Africa | 2022-02-18 |
| Efficacy of Metformin for Sputum Conversion in Patients With Active Pulmonary Tuberculosis (NCT05215990) | Mahidol University | 2022-01-15 |
| Validating the Use of Blood Transcriptomic Signatures for the Diagnosis of Active Pulmonary Tuberculosis (NCT04995406) | BioMérieux | 2022-01-03 |
| Epidemiologic Study to Assess the IGRA Positivity in Populations With a High TB Burden (NCT05190146) | Gates Medical Research Institute | 2021-12-20 |
| A Clinical Risk Score for Early Management of TB in Uganda (NCT05122624) | Johns Hopkins Bloomberg School of Public Health | 2021-11-10 |
| Absorption, Elimination and Safety of 14C-labeled Radioactive BTZ-043, a New Compound in TB Treatment (NCT04874948) | Michael Hoelscher | 2021-10-08 |
| Airborne Preventive Measures to Reduce New TB Infections in Household Contacts (NCT04938596) | Pontificia Universidad Catolica de Chile | 2021-10-04 |
| Clinical Trial to Investigate Therapeutic Vaccine (RUTI) Against Tuberculosis (TB) (NCT04919239) | Archivel Farma S.L. | 2021-09-22 |
| Evaluation of a Rapid Point-of-Care Serological Triage Test for Active TB (NCT04752592) | Norwegian Institute of Public Health | 2021-09-21 |
| A Trial to Evaluate the Male Reproductive Safety of Pretomanid in Adult Male Participants With Drug Resistant Pulmonary Tuberculosis (NCT04179500) | Global Alliance for TB Drug Development | 2021-09-16 |
| Cardiopulmonary Function and Quality of Life in Pulmonary Tuberculosis (NCT04844502) | Universidade Federal do Rio de Janeiro | 2021-04-07 |
| PredictEndTB Signature for Individualizing Treatment in Multidrug-Resistant Tuberculosis (NCT04783727) | Research Center Borstel | 2021-04-01 |
| Adjunctive Acetylsalicylic Acid and Ibuprofen for Tuberculosis (NCT04575519) | Fundació Institut Germans Trias i Pujol | 2021-03-04 |
| Study to Evaluate Safety, Tolerability, and the PK Profile of TBI-223 in Healthy Subjects (NCT04865536) | Global Alliance for TB Drug Development | 2021-02-03 |
| Treating Tuberculosis With the Lipid Lowering Drug Atorvastatin in Nigeria(ATORvastatin in Pulmonary TUBerculosis) (NCT04721795) | Obafemi Awolowo University Teaching Hospital | 2021-01-19 |
| DIAGNOSIS of PULMONARY TUBERCULOSIS Through HUMAN BREATH (TBENOSE) (NCT04682990) | University of Rome Tor Vergata | 2021-01-05 |
| Vitamin D Supplementation Effect In Children With Pulmonary Tuberculosis Treatment (NCT05073965) | Universitas Padjadjaran | 2020-12-01 |
| Point-of-care Triage Test for Active Tuberculosis (NCT04232618) | University of Stellenbosch | 2020-11-05 |
| Treatment Shortening of Drug-Sensitive Pulmonary Tuberculosis Using High Dose Rifampicin (Hi-DoRi-3) (NCT04485156) | Seoul National University Hospital | 2020-09-01 |
| Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion (NCT04147286) | University of Cape Town | 2020-07-14 |
| Evaluate Safety, Tolerability, PK of TBAJ-876 in Healthy Adults (NCT04493671) | Global Alliance for TB Drug Development | 2020-06-08 |
| Evaluation of the Efficacy and Safety of a 4-month Daily Regimen (2HZPM/2HPM) for Treatment of Pulmonary TB (NCT04856644) | Kaohsiung Veterans General Hospital. | 2020-01-01 |
| Novel Triple-dose Tuberculosis Retreatment Regimens: How to Overcome Resistance Without Creating More (NCT03862248) | Institute of Tropical Medicine, Belgium | 2019-09-30 |
| A Study to Validate and Improve an Automated Image Analysis Algorithm to Detect Tuberculosis in Sputum Smear Slides (NCT05899400) | Diascopic, LLC | 2019-09-15 |
| Xpert MTB/XDR Clinical Evaluation Trial (NCT03728725) | Foundation for Innovative New Diagnostics, Switzerland | 2019-07-11 |
| PCR Techniques of Dried Sputum Using a Spotcard (NCT04055584) | University Medical Center Groningen | 2019-07-02 |
| Evaluation of CRISPR-based Test for the Rapid Identification of TB in Pulmonary Tuberculosis Suspects (NCT04074369) | Huashan Hospital | 2019-05-01 |
| VDOT and Mobile Payments in Cambodia (NCT03547479) | University of Southern California | 2019-05-01 |
| Clinical Evaluation of the Truenat Point-of-care Tuberculosis Diagnostic Test (NCT03712709) | Foundation for Innovative New Diagnostics, Switzerland | 2019-03-12 |
| Adjunctive NAC in Adult Patients With Pulmonary Tuberculosis (NCT03702738) | The Aurum Institute NPC | 2019-03-01 |
| Study to Evaluate the Safety, Tolerability and Pharmacokinetics of PBTZ169 in Multiple Dosing (NCT03776500) | Innovative Medicines for Tuberculosis | 2019-02-21 |
| Study to Evaluate H56:IC31 in Preventing Rate of TB Recurrence (NCT03512249) | International AIDS Vaccine Initiative | 2019-01-31 |
| A Phase 1 Study to Evaluate Safety, Tolerability, and Pharmacokinetics of TBI-223 in Healthy Adults (NCT03758612) | Global Alliance for TB Drug Development | 2019-01-16 |
| Bronchial Washings in Sputum Scarce Cases of Pulmonary Tuberculosis (NCT03732014) | Faisal Faiyaz Zuberi | 2019-01-02 |
| A Pragmatic Randomised Study to Optimise Screening, Prevention and Care for Tuberculosis in Malawi (NCT03519425) | Liverpool School of Tropical Medicine | 2018-11-15 |
| GeneXpert Performance Evaluation for Linkage to Tuberculosis Care (NCT03044158) | University of California, San Francisco | 2018-10-22 |
| Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients (NCT03338621) | Global Alliance for TB Drug Development | 2018-07-30 |
| Acceptability and Feasibility of Home-based TB Testing (NCT04973371) | Foundation for Professional Development (Pty) Ltd | 2018-07-01 |
| A Single Ascending Dose Study of BTZ043 (NCT03590600) | Michael Hoelscher | 2018-06-07 |
| Rifampicin vs Rifabutin in HIV/AIDS Patients Combined With Tuberculosis (NCT03478033) | Shanghai Public Health Clinical Center | 2018-04-15 |
| Study on the Management Model of "Home Treatment" for Tuberculosis Patients (NCT03967353) | Beijing Chest Hospital | 2018-03-22 |
| Two-month Regimens Using Novel Combinations to Augment Treatment Effectiveness for Drug-sensitive Tuberculosis (NCT03474198) | University College, London | 2018-03-21 |
| Azithromycin as Host-directed Therapy for Pulmonary Tuberculosis (NCT03160638) | University Medical Center Groningen | 2018-02-01 |
| AI-based System for Lung Tuberculosis Screening: Diagnostic Accuracy Evaluation (NCT05889364) | Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department | 2018-02-01 |
| Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Ex-vivo Antitubercular Activity of PBTZ169 Formulation (NCT03423030) | Innovative Medicines for Tuberculosis | 2017-12-05 |
| Various Doses and Durations of Linezolid Plus Bedaquiline & Pretomanid in Participants With Drug Resistant Tuberculosis (NCT03086486) | Global Alliance for TB Drug Development | 2017-11-21 |
| Effect of Smoking Cessation on Tuberculosis Treatment Outcomes (NCT04848246) | Dow University of Health Sciences | 2017-11-06 |
| Nanodisk-MS Assay for the Diagnosis of Active Pulmonary and Extrapulmonary Tuberculosis in Hospitalized Patients (NCT03271567) | Chinese University of Hong Kong | 2017-09-28 |
| Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Sutezolid (NCT03199313) | Global Alliance for TB Drug Development | 2017-09-26 |
| TB Sequel: Pathogenesis and Risk Factors of Long-term Sequelae of Pulmonary TB (NCT03251196) | The Aurum Institute NPC | 2017-09-22 |
| Prevention of Tuberculosis in Prisons (NCT03028129) | Federal University of Mato Grosso | 2017-09-04 |
| A Phase 1 Study to Evaluate Safety, Tolerability, PK, and PK Interactions of TBA-7371 (NCT03199339) | Global Alliance for TB Drug Development | 2017-08-29 |
| Early Bactericidal Activity of Rifampin + Meropenem + Amoxicillin/Clavulanate in Adults With Pulmonary TB (NCT03174184) | Johns Hopkins University | 2017-08-23 |
| Treating Tuberculosis Wasting With a High-protein Supplement (NCT03302949) | University of Aarhus | 2017-08-01 |
| Early Diagnosis of Active Tuberculosis Using Ultra Low-dose Chest CT (NCT03220464) | Seoul National University Hospital | 2017-06-20 |
| Personalization of AntiTB Treatment: Evaluation of Pharmacological Determinants of Treatment Response (NCT03416309) | University of Turin, Italy | 2017-05-25 |
| Efficacy and Safety of Intravenous Treatment of Tuberculosis (NCT04150367) | Yuria-Pharm | 2017-03-03 |
| Pragmatic Clinical Trial for a More Effective Concise and Less Toxic MDR-TB Treatment Regimen(s) (NCT02589782) | Medecins Sans Frontieres, Netherlands | 2017-01-01 |
| RIPE vs RIPE Plus N-acetylcysteine in Patients With HIV/TB Co-infection (NCT03281226) | Fundação de Medicina Tropical Dr. Heitor Vieira Dourado | 2016-12-07 |
| Microbiome in Pulmonary Tuberculosis, Non-tuberculous Mycobacterial Pulmonary Diseases, Lung Cancer and Hemoptysis (NCT04079400) | Gachon University Gil Medical Center | 2016-12-01 |
| Evaluation of 11C-acetate PET Imaging as a Novel Approach to Detecting Pathology in Pulmonary TB (NCT02972697) | National University Hospital, Singapore | 2016-11-01 |
| Evaluation of PET/MRI Using a Somatostatin Analog Tracer as a Novel Approach to Detecting Pathology in High Risk TB-exposed Contacts (NCT02967666) | National University Hospital, Singapore | 2016-11-01 |
| Study of TB Lesions Obtained in Therapeutical Surgery (NCT02715271) | Fundació Institut Germans Trias i Pujol | 2016-09-01 |
| Shortened Regimens for Drug-susceptible Pulmonary Tuberculosis (NCT02901288) | Beijing Chest Hospital | 2016-08-01 |
| A New Treatment for Primary Smear-positive Pulmonary Tuberculosis With Interleukin-2 (NCT04766307) | Beijing Chest Hospital | 2016-07-20 |
| Probe Melting Technology for Rapid Detection of Drug Resistant Tuberculosis (NCT02776150) | Beijing Hospital | 2016-05-01 |
| Accuracy and Feasibility of Xpert Ultra (NCT03072576) | Foundation for Innovative New Diagnostics, Switzerland | 2016-03-01 |
| Integrated Discovery and Development of Innovative TB Diagnostics (NCT06624501) | Harvard University Faculty of Medicine | 2015-05-01 |
| IGRA and Mantoux Response in Children With Suspected Latent or Active TB Infection (NCT02653404) | University of Siena | 2015-04-01 |
| Diagnostic Trial to Validate the Use of the E-Nose in Pulmonary TB (NCT02768909) | Universidad Central de Venezuela | 2015-01-01 |
| Optimization of the TB Treatment Regimen Cascade (NCT02153528) | Damien Foundation | 2014-11-01 |
| Evaluation of SQ109, High-dose Rifampicin, and Moxifloxacin in Adults With Smear-positive Pulmonary TB in a MAMS Design (NCT01785186) | Michael Hoelscher | 2013-04-01 |
| Safety and Efficacy of Blocking IL-4 With Pascolizumab in Patients Receiving Standard Therapy for Pulmonary Tuberculosis (NCT01638520) | National University Hospital, Singapore | 2012-06-01 |
| Reintroduction Regimens After Hepatitis During Anti-tuberculosis Treatment (NCT01395654) | National Taiwan University Hospital | 2011-07-01 |
| Utility of MODS for Diagnosis of MDR-TB and Second-Line Antituberculous Drug Susceptibility Testing in Mali (NCT01381757) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-05-31 |
| Feasibility of a Lateral Flow Urine LAM Test for Diagnosis of Tuberculosis in South Africa (NCT01693224) | Tuberculosis Clinical Diagnostics Research Consortium | 2011-04-01 |
| Feasibility of a Lateral Flow Urine Lipoarabinomannan (LAM) Test for Diagnosis of Tuberculosis (NCT01525134) | Tuberculosis Clinical Diagnostics Research Consortium | 2011-01-01 |
| Pharmacokinetics of Anti-tuberculosis Drugs in Gastrectomized Patients (NCT01364324) | National Cancer Center, Korea | 2010-09-01 |
| Pharmacokinetics, Safety and Tolerability of Escalating Rifapentine Doses in Healthy Volunteers (NCT01162486) | Johns Hopkins University | 2010-04-01 |
| Clinical Analysis of the Patients With Cavitary Pulmonary TB and Endobronchial TB in the PPM-UUH Cohort (NCT03822156) | University of Ulsan | 2010-01-01 |
| Cost-effectiveness of Two Forms of DOTS in a Demonstration Area of the DOTS Strategy in Colombia (NCT01945905) | Fundación FES | 2009-12-01 |
| Replacement of Vitamin D in Patients With Active Tuberculosis (NCT01130311) | Aga Khan University | 2009-10-01 |
| A Trial to Evaluate OPC 67683 in Participants With Pulmonary Sputum Culture-positive, Multidrug-resistant Tuberculosis (TB) (NCT00685360) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2008-05-08 |
| Co-Infection of NTM in Patients With Smear Positive Pulmonary TB (NCT00567151) | Seoul National University Hospital | 2007-12-01 |
| MDR TB, Levofloxacin, Multi-Drug-Resistant Pulmonary Tuberculosis (NCT00495339) | Sanofi | 2007-06-01 |
| Trial of Adjunctive Vitamin D in Tuberculosis Treatment (NCT00419068) | Barts & The London NHS Trust | 2007-01-01 |
| Study of Interferon-Gamma in the Complex Treatment of Patients Infected With HIV and Tuberculosis (NCT05065905) | SPP Pharmaclon Ltd. | 2006-01-19 |
| The Effectiveness of Health Facility-based and Community-based Care for Tuberculosis (NCT00939419) | University of Leeds | 2005-01-01 |
| TBTC Study 27: Moxifloxacin vs Ethambutol for TB Treatment (NCT00140309) | Centers for Disease Control and Prevention | 2003-07-01 |
| Pilot Randomized Study of Paromomycin (Aminosidine) vs Streptomycin for Uncomplicated Pulmonary Tuberculosis (NCT00004444) | FDA Office of Orphan Products Development | 1994-11-01 |